Rajangam Kanya - Insider Non-Derivative Transactions at Senti Biosciences, Inc. (SNTI) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Mar 10, 2025, Rajangam Kanya's relationship to Senti Biosciences, Inc. (SNTI) is Officer (Pres. & Chief Med. & Dev. Off.), and currently has 33,000 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SNTI insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Rajangam Kanya - Insider Non-Derivative Transactions of SNTI Common Stock

Rajangam Kanya - Insider Non-Derivative Transactions at SNTI

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Mar 11, 2025	C -- (Common Stock)	33000	2.25	33000
Mar 8, 2025	Acquisition -- (Common Stock)	78363	0	86984
Feb 7, 2025	Sell -- (Common Stock)	182	4.37	8621
Feb 5, 2025	Sell -- (Common Stock)	1297	4.07	8803
Feb 2, 2024	Acquisition -- (Common Stock)	101000	0	101000